Company intelligence / Profile preview

Global Calcium

Bangalore, Karnataka, India

Ownership: Private
Employees: ~1400
Development stage: Other

Overview

Global Calcium consistently supplies USFDA- and EU-GMP-approved APIs and mineral actives for pharmaceutical, supplement, and food applications in global markets. Multiple therapeutic categories are covered. Clinical data for FruiteX-B calcium fructoborate developed in partnership with FutureCeuticals indicates efficacy in joint/bone health, though direct clinical stage programs for Global Calcium’s proprietary drugs are not disclosed.

Therapeutic areas: ImmunologyRheumatologyOphthalmologyPsychiatryInfectious DiseasesGastroenterologyHematologyCardiovascularNeurology
Modalities: Small moleculeMineral saltBulk drugSpecialty API
Industry: Contract Manufacturing Organization

Partnerships

FutureCeuticals (mineral complex FruiteX-B)

Beyond the preview

Go deeper on Global Calcium.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Global Calcium.

Explore the full profile